NO984949D0 - Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder - Google Patents

Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder

Info

Publication number
NO984949D0
NO984949D0 NO984949A NO984949A NO984949D0 NO 984949 D0 NO984949 D0 NO 984949D0 NO 984949 A NO984949 A NO 984949A NO 984949 A NO984949 A NO 984949A NO 984949 D0 NO984949 D0 NO 984949D0
Authority
NO
Norway
Prior art keywords
compounds
treatment methods
preparations containing
carbapenem antibacterial
antibacterial compounds
Prior art date
Application number
NO984949A
Other languages
English (en)
Other versions
NO984949L (no
Inventor
Robert R Wilkening
Ronald W Ratcliffe
Timothy A Blizzard
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609741.5A external-priority patent/GB9609741D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO984949D0 publication Critical patent/NO984949D0/no
Publication of NO984949L publication Critical patent/NO984949L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO984949A 1996-04-24 1998-10-23 Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder NO984949L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1618496P 1996-04-24 1996-04-24
GBGB9609741.5A GB9609741D0 (en) 1996-05-10 1996-05-10 Carbapenem antibacterial compounds compositions containing such componds and methods of treatment
PCT/US1997/006626 WO1997040048A1 (en) 1996-04-24 1997-04-21 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Publications (2)

Publication Number Publication Date
NO984949D0 true NO984949D0 (no) 1998-10-23
NO984949L NO984949L (no) 1998-12-21

Family

ID=26309297

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984949A NO984949L (no) 1996-04-24 1998-10-23 Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder

Country Status (31)

Country Link
EP (1) EP0906313B1 (no)
JP (1) JP3176068B2 (no)
KR (1) KR20000010599A (no)
CN (1) CN1074767C (no)
AR (1) AR006810A1 (no)
AT (1) ATE260915T1 (no)
AU (1) AU707459B2 (no)
BG (1) BG102949A (no)
BR (1) BR9708864A (no)
CA (1) CA2252402C (no)
CO (1) CO4990968A1 (no)
CZ (1) CZ340798A3 (no)
DE (1) DE69727931T2 (no)
EA (1) EA001296B1 (no)
EE (1) EE03689B1 (no)
ES (1) ES2216142T3 (no)
HK (1) HK1021186A1 (no)
HR (1) HRP970213A2 (no)
HU (1) HUP9901778A3 (no)
ID (1) ID16662A (no)
IL (1) IL126480A0 (no)
IS (1) IS4861A (no)
NO (1) NO984949L (no)
NZ (1) NZ332183A (no)
PE (1) PE64298A1 (no)
PL (1) PL186881B1 (no)
SK (1) SK283550B6 (no)
TR (1) TR199802140T2 (no)
TW (1) TW539677B (no)
WO (1) WO1997040048A1 (no)
YU (1) YU46298A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406457B1 (en) 1994-03-02 2002-06-18 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US7163522B1 (en) 1994-03-02 2007-01-16 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
WO1998051677A1 (en) * 1997-05-13 1998-11-19 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US5908936A (en) * 1997-05-13 1999-06-01 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
JP2002509856A (ja) * 1997-10-23 2002-04-02 メルク エンド カムパニー インコーポレーテッド カルバペネム系抗菌化合物、組成物および治療方法
AU752313B2 (en) * 1997-10-23 2002-09-12 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6140318A (en) 1997-10-23 2000-10-31 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
EP1104424B1 (en) * 1998-06-17 2004-04-07 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates
AU4711799A (en) * 1998-06-25 2000-01-10 Merck & Co., Inc. (heterocyclic) methyl substituted carbapenem antibacterials
JP2002518446A (ja) * 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド カルバペネム抗菌性化合物、前記化合物を含む組成物及び治療方法
US7672747B2 (en) 2000-03-30 2010-03-02 Lam Research Corporation Recipe-and-component control module and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use

Also Published As

Publication number Publication date
HUP9901778A2 (hu) 1999-09-28
PL186881B1 (pl) 2004-03-31
EE03689B1 (et) 2002-04-15
EE9800355A (et) 1999-04-15
YU46298A (sh) 2000-03-21
JP3176068B2 (ja) 2001-06-11
WO1997040048A1 (en) 1997-10-30
EP0906313A1 (en) 1999-04-07
IS4861A (is) 1998-10-06
KR20000010599A (ko) 2000-02-15
AU707459B2 (en) 1999-07-08
PL329376A1 (en) 1999-03-29
PE64298A1 (es) 1998-10-30
DE69727931D1 (de) 2004-04-08
NZ332183A (en) 2000-05-26
CN1222912A (zh) 1999-07-14
JPH11508279A (ja) 1999-07-21
IL126480A0 (en) 1999-08-17
HUP9901778A3 (en) 2000-06-28
EA001296B1 (ru) 2000-12-25
NO984949L (no) 1998-12-21
EA199800949A1 (ru) 1999-04-29
BG102949A (bg) 1999-10-29
AR006810A1 (es) 1999-09-29
ATE260915T1 (de) 2004-03-15
HK1021186A1 (en) 2000-06-02
SK145498A3 (en) 1999-10-08
HRP970213A2 (en) 1998-06-30
CN1074767C (zh) 2001-11-14
ES2216142T3 (es) 2004-10-16
BR9708864A (pt) 1999-08-03
SK283550B6 (sk) 2003-09-11
CO4990968A1 (es) 2000-12-26
DE69727931T2 (de) 2005-04-14
CA2252402C (en) 2002-12-24
CZ340798A3 (cs) 1999-03-17
CA2252402A1 (en) 1997-10-30
AU2462997A (en) 1997-11-12
TW539677B (en) 2003-07-01
ID16662A (id) 1997-10-30
EP0906313B1 (en) 2004-03-03
TR199802140T2 (xx) 1999-01-18

Similar Documents

Publication Publication Date Title
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
DE59406123D1 (de) Haarbehandlungsmittel
NO983266D0 (no) Distribuert Behandling
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO984431L (no) FremgangsmÕte for behandling av smerte
TR199501053A2 (tr) Tedavide yararli spiro-azabisiklik bilesikler.
DE69435201D1 (de) Sterilisationshüllensystem
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
NO932996D0 (no) Utvendig kateter, applikator og fremgangsmaate for bruken
NO944464D0 (no) Framgangsmåte for sikker kommunikasjon
NO984949L (no) Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder
DE19681419T1 (de) Behandlungssystem
ID17723A (id) Senyawa untuk pengobatan
NO983263L (no) Distribuert behandling
IS4789A (is) Meðferðarefnasambönd
NO984446D0 (no) FremgangsmÕte for behandling av smerte
DE69714504T2 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
NO961733D0 (no) Fremgangsmåte for desinfisering og törking
ID16924A (id) Metode perlakuan poliolefin
EP1021445A4 (en) ANTIBACTERIAL CARBAPENEM COMPOSITIONS, PREPARATIONS CONTAINING SAME, AND METHODS OF TREATMENT
EP0977567A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, CONTAINING COMPOSITIONS AND TREATMENT METHODS
EP1032384A4 (en) ANTIBACTERIAL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING CARBAPENEMAS
EP1027352A4 (en) ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPOSITIONS AND TREATMENT METHODS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application